Compare DVA & CWAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | CWAN |
|---|---|---|
| Founded | 1994 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 7.1B |
| IPO Year | 2002 | 2021 |
| Metric | DVA | CWAN |
|---|---|---|
| Price | $152.23 | $23.53 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 11 |
| Target Price | ★ $156.75 | $25.09 |
| AVG Volume (30 Days) | 1.4M | ★ 10.9M |
| Earning Date | 05-04-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.84 | N/A |
| Revenue | ★ $13,643,069,000.00 | $731,368,000.00 |
| Revenue This Year | $3.80 | $31.86 |
| Revenue Next Year | $3.04 | $18.11 |
| P/E Ratio | $15.66 | ★ N/A |
| Revenue Growth | 6.46 | ★ 61.88 |
| 52 Week Low | $101.00 | $15.74 |
| 52 Week High | $159.42 | $30.85 |
| Indicator | DVA | CWAN |
|---|---|---|
| Relative Strength Index (RSI) | 66.40 | 51.11 |
| Support Level | $135.14 | $23.22 |
| Resistance Level | N/A | $24.33 |
| Average True Range (ATR) | 4.63 | 0.28 |
| MACD | -0.32 | 0.01 |
| Stochastic Oscillator | 66.18 | 75.00 |
DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
Clearwater Analytics describes its mission as aiming to be the world's most trusted and comprehensive technology platform for the entire investment cycle. Clearwater has historically focused on back-office functions such as investment accounting, but with acquisitions such Enfusion, Beacon, and Bistro, the firm has broadened its focus with front-office and middle-office capabilities. Clearwater primarily serves insurance companies, asset managers, hedge funds, and corporate treasuries. Pro forma for Enfusion, about 76% of Clearwater's revenue is generated in the US.